(Q37937667)

English

Therapeutic potential for HDAC inhibitors in the heart

scientific article published on 26 September 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

title

Therapeutic potential for HDAC inhibitors in the heart (English)

1 reference

stated in

Europe PubMed Central

25 August 2017

Timothy A McKinsey

1

1 reference

stated in

Europe PubMed Central

25 August 2017

26 September 2011

1 reference

stated in

Europe PubMed Central

25 August 2017

Annual Review of Pharmacology and Toxicology

1 reference

stated in

Europe PubMed Central

25 August 2017

52

1 reference

stated in

Europe PubMed Central

25 August 2017

303-319

1 reference

stated in

Europe PubMed Central

25 August 2017

HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M110.163865

Identifiers

DOI

10.1146/ANNUREV-PHARMTOX-010611-134712

1 reference

stated in

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

PubMed ID

21942627

retrieved

25 August 2017

(Q37937667)

Therapeutic potential for HDAC inhibitors in the heart

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)